A61K 38/208
Il-12
Official title: {il-12}
A61K38/208 (Il-12) appears on 434 US grants and 847 published applications in this corpus.
Search patents in A61K- Granted patents
- 434
- Published applications
- 847
- Assignees
- 365
- Inventors
- 1,417
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 4 | 0 |
| 1999 | 6 | 0 |
| 2000 | 3 | 0 |
| 2001 | 3 | 3 |
| 2002 | 11 | 9 |
| 2003 | 6 | 19 |
| 2004 | 6 | 25 |
| 2005 | 6 | 23 |
| 2006 | 5 | 25 |
| 2007 | 5 | 21 |
| 2008 | 11 | 13 |
| 2009 | 5 | 23 |
| 2010 | 10 | 26 |
| 2011 | 10 | 30 |
| 2012 | 13 | 25 |
| 2013 | 9 | 30 |
| 2014 | 21 | 37 |
| 2015 | 20 | 29 |
| 2016 | 24 | 34 |
| 2017 | 31 | 34 |
| 2018 | 26 | 44 |
| 2019 | 28 | 57 |
| 2020 | 21 | 47 |
| 2021 | 32 | 52 |
| 2022 | 28 | 64 |
| 2023 | 26 | 51 |
| 2024 | 27 | 48 |
| 2025 | 19 | 45 |
| 2026 | 14 | 33 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Protein-enclosing polymeric micelle11 Aug 2026US 12,702,718 B2The University of Tokyo
- Cell immunotherapy for the treatment of cancer14 Jul 2026US 12,678,486 B2Board of Regents, The University of Texas System
- Nanoparticle modification of human adipose-derived mesenchymal stem cells for treating brain cancer and other neurological diseases2 Jun 2026US 12,642,817 B2The Johns Hopkins University
- Aryl pladienolides for the treatment of neoplastic disorders12 May 2026US 12,622,905 B2Eisai R&D Management Co., Ltd.
- Anti-tumor composition12 May 2026US 12,622,936 B2Genemedicine Co., Ltd.
- Il-12 mutants with reduced toxicity, compositions thereof and methods of using the same1 Oct 2026US 2026/0295010 A1
- Cell immunotherapy for the treatment of cancer1 Oct 2026US 2026/0295011 A1Board of Regents, The University of Texas System
- Reducing systemic regulatory t cell levels or activity for treatment of disease and injury of the cns1 Oct 2026US 2026/0297191 A1ImmunoBrain Checkpoint, Inc.
- Use of oncolytic viruses for the treatment of cancer24 Sep 2026US 2026/0286393 A1Amgen Inc.
- Activatable cytokine polypeptides and methods of use thereof27 Aug 2026US 2026/0250345 A1Werewolf Therapeutics, Inc.
Most cited
By later US patents
- Handheld electromechanical surgical system627US 10,932,784 B2Covidien LP · 2021
- Human antibodies that bind human IL-12 and methods for producing300US 6,914,128 B1Abbott GmbH & Co. KG · 2005
- Adoptive cell therapy with young T cells191US 8,383,099 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2013
- Multiple cytokine protein complexes145US 6,617,135 B1EMD Lexigen Research Center Corp. · 2003
- Adoptive cell therapy with young T cells137US 9,074,185 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2015